JHS Svendgaard Laboratories Limited (NSE:JHS)

Market Cap	1.20B
Revenue (ttm)	890.97M
Net Income (ttm)	-249.43M
Shares Out	85.60M
EPS (ttm)	-3.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,824
Average Volume	71,138
Open	13.63
Previous Close	14.03
Day's Range	13.63 - 14.20
52-Week Range	11.00 - 32.69
Beta	0.38
RSI	46.74
Earnings Date	May 19, 2025

About NSE:JHS

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil bra...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1997
• Employees: 250
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JHS

Financial Performance

In 2023, NSE:JHS's revenue was 728.93 million, a decrease of -20.04% compared to the previous year's 911.59 million. Losses were -154.64 million, 281.6% more than in 2022.